Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116


Systematic selection of screening participants by risk score in a Chlamydia screening programme is feasible and effective.

van den Broek IV, Brouwers EE, Götz HM, van Bergen JE, Op de Coul EL, Fennema JS, Koekenbier RH, Pars LL, van Ravesteijn SM, Hoebe CJ.

Sex Transm Infect. 2012 Apr;88(3):205-11. doi: 10.1136/sextrans-2011-050219. Epub 2012 Jan 3.


Rationale, design, and results of the first screening round of a comprehensive, register-based, Chlamydia screening implementation programme in the Netherlands.

van Bergen JE, Fennema JS, van den Broek IV, Brouwers EE, de Feijter EM, Hoebe CJ, Koekenbier RH, de Coul EL, van Ravesteijn SM, Götz HM.

BMC Infect Dis. 2010 Oct 7;10:293. doi: 10.1186/1471-2334-10-293.


Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation.

van den Broek IV, van Bergen JE, Brouwers EE, Fennema JS, Götz HM, Hoebe CJ, Koekenbier RH, Kretzschmar M, Over EA, Schmid BV, Pars LL, van Ravesteijn SM, van der Sande MA, de Wit GA, Low N, Op de Coul EL.

BMJ. 2012 Jul 5;345:e4316. doi: 10.1136/bmj.e4316.


Who participates in the Dutch Chlamydia screening? A study on demographic and behavioral correlates of participation and positivity.

Op de Coul EL, Götz HM, van Bergen JE, Fennema JS, Hoebe CJ, Koekenbier RH, Pars LL, van Ravesteijn SM, van der Sande MA, van den Broek IV.

Sex Transm Dis. 2012 Feb;39(2):97-103. doi: 10.1097/OLQ.0b013e3182383097.


Evaluation design of a systematic, selective, internet-based, Chlamydia screening implementation in the Netherlands, 2008-2010: implications of first results for the analysis.

van den Broek IV, Hoebe CJ, van Bergen JE, Brouwers EE, de Feijter EM, Fennema JS, Götz HM, Koekenbier RH, van Ravesteijn SM, de Coul EL.

BMC Infect Dis. 2010 Apr 7;10:89. doi: 10.1186/1471-2334-10-89.


Reinfections, persistent infections, and new infections after general population screening for Chlamydia trachomatis infection in the Netherlands.

Veldhuijzen IK, Van Bergen JE, Götz HM, Hoebe CJ, Morré SA, Richardus JH; PILOT CT Study Group.

Sex Transm Dis. 2005 Oct;32(10):599-604.


Acceptability of the internet-based Chlamydia screening implementation in the Netherlands and insights into nonresponse.

Greenland KE, Op de Coul EL, van Bergen JE, Brouwers EE, Fennema HJ, Götz HM, Hoebe CJ, Koekenbier RH, Pars LL, van Ravesteijn SM, van den Broek IV.

Sex Transm Dis. 2011 Jun;38(6):467-74. doi: 10.1097/OLQ.0b013e318204546e.


Screening Belgian university students for Chlamydia trachomatis infection: a feasibility study.

Colliers A, Verster A, Van Puyenbroeck K, Stalpaert M, Van Royen P, Verhoeven V.

Int J Adolesc Med Health. 2009 Jul-Sep;21(3):343-6.


A prediction rule for selective screening of Chlamydia trachomatis infection.

Götz HM, van Bergen JE, Veldhuijzen IK, Broer J, Hoebe CJ, Steyerberg EW, Coenen AJ, de Groot F, Verhooren MJ, van Schaik DT, Richardus JH.

Sex Transm Infect. 2005 Feb;81(1):24-30. Erratum in: Sex Transm Infect. 2005 Aug;81(4):362. Steyerberg, EW [added]; Coenen, AJJ [added]; de Groot, F [added]; Verhooren, MJC [added]; van Schaik, DT [added].


Non-participation in chlamydia screening in The Netherlands: determinants associated with young people's intention to participate in chlamydia screening.

ten Hoor GA, Ruiter RA, van Bergen JE, Hoebe CJ, Houben K, Kok G.

BMC Public Health. 2013 Nov 23;13:1091. doi: 10.1186/1471-2458-13-1091.


Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection.

Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, Horner P, Skidmore S, Sterne JA, Sanford E, Ibrahim F, Holloway A, Patel R, Barton PM, Robinson SM, Mills N, Graham A, Herring A, Caul EO, Davey Smith G, Hobbs FD, Ross JD, Egger M; Chlamydia Screening Studies Project Group.

Health Technol Assess. 2007 Mar;11(8):iii-iv, ix-xii, 1-165. Review.


[Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population of Amsterdam. Il Over 90% participation and almost 5% prevalence].

van den Hoek JA, Mulder-Folkerts DK, Coutinho RA, Dukers NH, Buimer M, van Doornum GJ.

Ned Tijdschr Geneeskd. 1999 Mar 27;143(13):668-72. Dutch.


Acceptability of urine-based screening for Chlamydia trachomatis in asymptomatic young men: a systematic review.

Marrazzo JM, Scholes D.

Sex Transm Dis. 2008 Nov;35(11 Suppl):S28-33. doi: 10.1097/OLQ.0b013e31816938ca. Review.


The added value of chlamydia screening between 2008-2010 in reaching young people in addition to chlamydia testing in regular care; an observational study.

van Liere GA, Dukers-Muijrers NH, van Bergen JE, Götz HM, Stals F, Hoebe CJ.

BMC Infect Dis. 2014 Nov 18;14:612. doi: 10.1186/s12879-014-0612-2.


Developments in the screening for Chlamydia trachomatis: a review.

Kohl KS, Markowitz LE, Koumans EH.

Obstet Gynecol Clin North Am. 2003 Dec;30(4):637-58. Review.


Effects of population based screening for Chlamydia infections in the Netherlands limited by declining participation rates.

Schmid BV, Over EA, van den Broek IV, Op de Coul EL, van Bergen JE, Fennema JS, Götz HM, Hoebe CJ, de Wit GA, van der Sande MA, Kretzschmar ME.

PLoS One. 2013;8(3):e58674. doi: 10.1371/journal.pone.0058674. Epub 2013 Mar 20.


[Systematic home screening for Chlamydia trachomatis infections of asymptomatic men and women in family practice by means of mail-in urine samples].

van Valkengoed IG, Boeke AJ, van den Brule AJ, Morré SA, Dekker JH, Meijer CJ, van Eijk JT.

Ned Tijdschr Geneeskd. 1999 Mar 27;143(13):672-6. Dutch.


Low diagnostic accuracy of selective screening criteria for asymptomatic Chlamydia trachomatis infections in the general population.

van Valkengoed IG, Morré SA, van den Brule AJ, Meijer CJ, Devillé W, Bouter LM, Boeke AJ.

Sex Transm Infect. 2000 Oct;76(5):375-80.

Supplemental Content

Support Center